Valneva confirms amendment of advance purchase agreement with european commission for valneva's inactivated covid-19 vaccine

Saint- herb lain (france ) , august 1 , 2 02 2 – valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company, today confirms the signing of the amendment to its advance purchase agreement (apa)1 with the european commission (ec), following expiration of the member states' opt-out period, as announced by the company on july 20, 20222. under this amendment, the member states' purchases of vla2001, valneva's inactivated whole-virus covid-19 vaccine, consist of 1.25 million doses of vla2001 in 2022, with the option to purchase an equivalent quantity later this year for delivery in 2022.
VALN Ratings Summary
VALN Quant Ranking